BioCentury
ARTICLE | Clinical News

Fanapt iloperidone regulatory update

May 11, 2009 7:00 AM UTC

FDA approved an NDA from Vanda for Fanapt iloperidone to treat schizophrenia in adults. Vanda plans to launch the product later this year. Fanapt is a serotonin (5-HT2) receptor and dopamine receptor...